# Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/weekly-vs-every-3-week-paclitaxel-and-carboplatin-for-ovarian-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John K. Chan,Mark F. Brady,Richard T. Penson,Helen Huang,Michael J. Birrer,Joan L. Walker,Paul DiSilvestro,Stephen C. Rubin,Lainie P. Martin,Susan A. Davidson,Warner K. Huh,David M. O’Malley,Matthew Boente,Helen Michael,Bradley J. Monk |
| Citations | 369 |
| DOI | 10.1056/nejmoa1505067 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1505067?articleTools=true |
| OpenAlex ID | https://openalex.org/W2329492928 |
| PMID | 26933849 |
| Type | article |
| Year | 2016 |

## Paper authors

- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)
- [Paul DiSilvestro](https://scholariq.org/researchers/paul-disilvestro/)
- [Lainie P. Martin](https://scholariq.org/researchers/lainie-p-martin/)
- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.